Shares of ANGLE plc (LON:AGL – Get Free Report) fell 11.3% during mid-day trading on Tuesday. The company traded as low as GBX 2.33 and last traded at GBX 2.35. Approximately 1,682,496 shares traded hands during mid-day trading, an increase of 4% from the average daily volume of 1,623,727 shares. The stock had previously closed at GBX 2.65.
ANGLE Price Performance
The company has a current ratio of 2.76, a quick ratio of 6.17 and a debt-to-equity ratio of 25.25. The firm has a market capitalization of £7.58 million, a price-to-earnings ratio of -0.49 and a beta of 0.22. The company’s 50 day moving average is GBX 2.35 and its 200-day moving average is GBX 2.35.
About ANGLE
ANGLE plc, a medical diagnostic company, engages in developing cancer diagnostics products in Europe, North America, and the United Kingdom. The company develops and commercializes Parsortix cell separation system, which captures and harvests circulating tumor cells in metastatic breast cancer patient blood; and HyCEAD. ANGLE plc has a partnership agreement with Bio View Ltd to develop a liquid biopsy circulating tumor cell HER2 assay for breast cancer. The company was founded in 1994 and is based in Guildford, the United Kingdom.
Recommended Stories
- Five stocks we like better than ANGLE
- Why Kinder Morgan’s Chairman Just Bought $15 Million in Stock
- Rocket Lab’s Record Backlog Could Fuel a Rebound, But Neutron Raises the Stakes
- Don’t Let Their Low Yields Fool You: 3 Dividend Stocks Worth Watching
- A $4 Billion Jolt: NRG Energy Powers Data Center Ambitions
Receive News & Ratings for ANGLE Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ANGLE and related companies with MarketBeat.com's FREE daily email newsletter.
